A conditional null mutation of peroxisome proliferator-activated receptor-binding protein (PBP) gene was generated to understand its role in mammary gland development. PBP-deficient mammary glands exhibited retarded ductal elongation during puberty, and decreased alveolar density during pregnancy and lactation. PBP-deficient mammary glands could not produce milk to nurse pups during lactation. Both the mammary ductal elongation in response to estrogen treatment and the mammary lobuloalveolar proliferation stimulated by estrogen plus progesterone were attenuated in PBPdeficient mammary glands. The proliferation index was decreased in PBP-deficient mammary glands. PBP-deficient mammary epithelial cells expressed abundant ␤-casein, whey acidic protein, and WDNM1 mRNA, indicating a relatively intact differentiated function. PBPdeficient epithelial cells were unable to form mammospheres, which were considered to be derived from mammary progenitor/stem cells. We conclude that PBP plays a pivotal role in the normal mammary gland development.
Steroid hormones play an essential role in regulating mammary gland development (1, 2) . During puberty, estrogen stimulates accelerated ductal growth, which finally fills the entire fat pad in mammary glands. Estrogen acts through estrogen receptors in the stromal and epithelial cells for the ductal growth of mammary glands (3, 4) . During early pregnancy, estrogen and progesterone are responsible for the lobuloalveolar proliferation (5, 6) . Progesterone receptors in mammary epithelial cells, which act in a paracrine fashion, are essential for alveolar branching (7) (8) (9) . Steroid hormones also play an important role in breast cancer development (10) . The exposure to excessive estrogen increases the risk of breast cancer, whereas estrogen antagonist tamoxifen decreased the incidence of breast cancer in clinical trials (11) . About 70% of breast cancers express estrogen receptor and about half of the estrogen receptor-positive breast cancers are responsive to anti-estrogen therapy (12, 13) . In addition, there are lines of evidence suggesting that pregnancy provides certain protection against breast cancers (14) .
Estrogen receptor and progesterone receptor are inducible transcription factors belonging to the nuclear receptor superfamily (15, 16) . Nuclear receptors require nuclear receptor coactivators for their transcriptional functions (17, 18) . Coactivators steroid receptor coactivator-1 and CBP (cAMP-response element-binding protein (CREB)-binding protein) act by modifying the chromatin structure through their histone acetyltransferase activities (17, 19) . Peroxisome proliferator-activated receptor-binding protein (PBP) 1 serves as the anchor for recruiting the mediator complex, which is composed of multiple proteins and facilitates transcriptional initiation (20, 21) . PBP has been shown to be required for adipogenesis (22) and peroxisome proliferator-induced responses in liver (23) . PBP was found to be amplified and overexpressed in some breast cancers and might play a role in tumorigenesis (24) . Because estrogen and progesterone signaling pathways play an essential role in mammary gland development, it would be important to elucidate the physiological function of PBP in mammary gland development. However, the observation that PBP null mutation is embryonic lethal excludes the analysis of the role of PBP in mammary gland development (25, 26) .
Here we report the generation of PBP null mutation in mammary glands. PBP-deficient mammary glands exhibit retarded ductal elongation and branching, impaired lobuloalveolar development, incapacity to produce milk to foster pups even with relatively intact expression of milk proteins, and attenuated response to the treatment of estrogen or estrogen plus progesterone. These results suggest that PBP is an important coactivator for the normal mammary gland development.
MATERIALS AND METHODS

Generation of PBP Null Mutation in Mammary
Glands-MMTV-Cre transgenic mice were obtained from the Mouse Models of Human Cancers Consortium Repository at National Cancer Institute, Frederick (27) . The PBP loxP mice (23) were bred with MMTV-Cre transgenic mice to generate PBP loxP MMTV-Cre mice, which were interbred to produce homozygous mutants (PBP loxP/loxP MMTV-Cre) with deletion of the DNA fragment between LoxP1 and LoxP3. PCR genotyping of mice was performed with the following primers: 5Ј-TCCATCTGACCTGCTGG-ATGATAA-3Ј and 5Ј-GGGTGTGACCCCATAATT-3Ј. Cre recombinase transgene was detected by PCR using the primers 5Ј-AGGTGTAGA-GAAGGCACTCAGC-3Ј and 5Ј-CTAATCGCCATCTTCCAGCAGG-3Ј. PBP loxP/loxP mice were used as the wild type control in all experiments. Whole Mount, Histology, and Immunostaining-A minimum of six age-and weight-matched female mice of each genotype (wild type and knock-out) were sacrificed by age as indicated for the analysis of mammary gland development. For whole-mount examination of the inguinal mammary glands, mammary glands were isolated, fixed in Carnoy's fixative, and stained overnight in hematoxylin (28) . Samples were then cleared in xylene and mounted. The extent of ductal outgrowth was measured as the distance from the center of the lymph node to the leading edge of the ductal mass. For histological assessment, mammary glands were isolated, fixed by formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (29) . Immunostaining was performed on sections from paraffin-embedded tissues. After being deparaffinized and rehydrated, the endogenous peroxidase activity on tissue sections was inactivated. Sections were then sequentially blocked with 10% normal bovine serum in phosphate-buffered saline, incubated at room temperature with anti-PBP antibody for 3 h, incubated with biotinylated goat anti-rabbit IgG for 1 h, treated with streptavidinlinked horseradish peroxidase for 30 min, and finally stained with 3,3Ј-diaminobenzidine tetrahydrochloride solution for 4 min. Sections were counterstained with hematoxylin.
Bromodeoxyuridine (BrdUrd) Staining-Two hours before being sacrificed, 12 mice (6 PBP LoxP/LoxP MMTV-Cre mice, 6 wild type mice) were given an intraperitoneal injection of BrdUrd (30 g of BrdUrd/g of body weight). Mammary glands were isolated, fixed, embedded, and sectioned. BrdUrd immunostaining was performed with the Cell Proliferation kit (Amersham Biosciences) as instructed by the manufacturer. A total of 6000 epithelial cells were counted from six mice for each genotype, with 1000 cells per mouse.
Isolation of Mammary Epithelial Cells, RNA Isolation, and Semiquantitative RT-PCR-The inguinal glands were collected from wild type and PBP mutant mice. Mammary epithelial cells were separated from stromal cells by collagenase digestion and Percoll gradient centrifugation (30) and used for the preparation of total RNA by the TRizol (Invitrogen) method. RT-PCR was performed with SuperScript one-step RT-PCR kit from Invitrogen. A sample of 1 g of total RNA was reversetranscribed with SuperScript II reverse transcriptase followed by PCR amplification consisting of 35 cycles of denaturing at 94°C for 15 s, annealing at 55°C for 30 s, and extension at 68°C for 1 min. For each 100-l reaction, 10 Ci of [ 35 S]dATP was included, and 20 l of amplified product was taken out at cycles 25 and 30. A 5-l aliquot of PCR product was separated on PAGE, which was then dried and exposed to x-ray film. The primers used were as follows: ␤-actin, 5Ј-C-CATCTACGAGGGCTATGCT-3Ј and 5Ј-GCAAGTTAGGTTTTGTCAA-AGA-3Ј. PBP, 5Ј-TGTATCTGGCTCTCCAATCC-3Ј and 5Ј-AGTGATG-AGTTCATACAGGGG-3Ј; ␤-casein, 5Ј-TCCTCTCTTGTCCTCCACTA-3Ј and 5Ј-TGTAGCATGATCCAAAGGTGA-3Ј; WDNM1, 5Ј-GTCAGAGC-CAACATGAAGAC-3Ј and 5Ј-GGATGCTAAGGATAGTTTATTTTAG-3Ј; whey acidic protein, 5Ј-CCTGACACCGGTACCATGCG-3Ј and 5Ј-ATG-TTCTCTCTGGATCCACG-3Ј; WISP2, 5Ј-GGATGGAGGTCTTTCTTG-CT-3Ј and 5Ј-GGCCATTCACCTCACAGCT-3Ј; progesterone receptor, 5Ј-CTCAACTACCTGAGGCCAGA-3Ј and 5Ј-TGTCATGCCCTGCATA-GATCA-3Ј; diamine oxidase, 5Ј-GGCAGGCACCAAGAACAGCT-3Ј and 5Ј-GCCACCAGATCCTCATTTTCA-3Ј.
Mammosphere Culture-The inguinal glands were collected from wild type and PBP mutant mice (6 mice/genotype). Cells were filtered sequentially through a 100-m and a 40-m cell strainer to obtain a single cell suspension. Single cells were plated in ultralow attachment plates at a density of 20,000 cells/ml. Cells were grown in a serum-free mammary epithelial growth medium (MEGM, BioWhittaker) supplemented with B27 (Invitrogen), 20 ng/ml epidermal growth factor, 20 ng/ml bovine fibroblast growth factor, and 4 g/ml heparin. The mammospheres were counted 2 weeks later.
Microarray Hybridization-Two day-lactating mice were sacrificed, and the #3-5 mammary glands were harvested. Mammary epithelial cells were isolated and used for the preparation of total RNA by 
RESULTS
Generation of PBP Mutation in Mammary
Glands-To create PBP null mutation in mammary glands, we crossed mice carrying LoxP integrated recombinant PBP gene (PBP LoxP ) with MMTV-Cre transgenic mice. MMTV-Cre transgenic mice specifically express Cre recombinase in mammary epithelial cells (27) . The PBP exon 8 -10, which were flanked by two LoxP sites, were deleted in mammary epithelial cells by Cre recombinase (Fig. 1A) . The homozygous mice carrying two copies of LoxP-integrated PBP genes (PBP LoxP/LoxP ) plus the Cre transgene were identified by PCR (Fig. 1B) . Semi-quantitative RT-PCR revealed that PBP mRNA in the mammary epithelial cells derived from PBP LoxP/LoxP MMTV-Cre mammary glands were substantially decreased, accounting for less than 5% that from wild type mammary epithelial cells (Fig. 1C) . Given that the mammary epithelial cells isolated from mammary glands through collagenase digestion and Percoll gradient centrifugation were always contaminated with a small number of adipocytes that expressed PBP mRNA, the percentage of mammary epithelial cells with PBP mutation in PBP LoxP/LoxP MMTV-Cre mammary glands should be higher than 95%. Immunohistochemical staining with anti-PBP antibody confirmed that more than 99% of mammary epithelial cells from PBP LoxP/LoxP MMTV-Cre mice did not express PBP protein (Fig. 1D) .
Defective Mammary Gland Development during Puberty, Pregnancy, and Lactation-We examined mammary glands at different developmental stages from age-and weight-matched PBP LoxP/LoxP mice and PBP LoxP/LoxP MMTV-Cre mice. During puberty, mammary ducts extend and branch into fat pads under the stimulation of estrogen. By 10 weeks ductal growth almost reached the edge of the fat pad in wild type mice (Fig.  2I) . The mammary ducts from 10-week-old PBP mutant mice only penetrated about half of the fat pad. However, histological examination revealed no appreciable difference between wild type and PBP-deficient mammary glands (data not shown).
During pregnancy, mammary glands undergo further ductal branching, lobuloalveolar proliferation, and differentiation. Whole mount preparation of glands from 15-day pregnant mice revealed that PBP deficiency caused impairment of lobuloalveolar development (Fig. 2II) . The density of alveoli in PBPnull mammary glands was markedly reduced as compared with that in wild type mammary glands (Fig. 2II) . However, the morphology of the alveolus, as revealed by H and E section, was indistinguishable in wild type and PBP-null mammary glands (data not shown).
PBP LoxP/LoxP MMTV-Cre mice delivered regular-sized litters (7 pups per litter on average), but none of the 40 pups from the 6 litters we observed could survive. All pups died within 36 h than wild type mammary glands (A). On hematoxylin and eosin sections (C and D), PBP-deficient mammary glands showed abundant adipocytes surrounding few alveoli, whereas wild type mammary glands contained well developed alveoli with rare adipocytes. Images are representative of glands from six mice per genotype.
after birth with no milk detected in their stomachs. However, pups could be fostered by wild type females, indicating that PBP-deficient mammary glands were unable to produce milk to nurse pups due to defective mammary gland development. An examination of wild type lactating mammary glands at day 2 revealed well developed lobuloalveoli with little remaining fat tissue (Fig. 2III) . The individual secretory alveoli were enlarged with spacious lumen containing milk. However, the mammary glands from PBP LoxP/LoxP MMTV-Cre mice showed much scant and small lobuloalveoli with abundant adipocytes (Fig. 2III) . In addition, the alveoli contained very small lumens.
Attenuation of Mammary Gland Response to the Treatment of Estrogen or Estrogen Plus
Progesterone-To examine the mammary duct growth in response to estrogen treatment, 3-weekold mice were implanted with estrogen pellets after being ovariectomized. The uterine and mammary glands were examined 3 weeks later. The successful implantation of estrogen pellets was confirmed by the observation that the uterine weight was increased ϳ10-fold in both wild type and PBP LoxP/LoxP MMTVCre mice. The whole mount of the fourth pair of mammary glands from wild type mice exhibited extensive ductal elongation and branching, which occupied almost the whole fat pad (Fig. 3, A and  C) . In contrast, PBP LoxP/LoxP MMTV-Cre mammary glands only contained a few short ducts, which had just extended to the lymph node (Fig. 3, B and C) , indicating that PBP is required for efficient ductal growth of mammary glands stimulated by estrogen. We also examined the expression of the estrogen-inducible gene WISP2 (WNT1-inducible signaling pathway protein 2), progesterone receptor, and diamine oxidase in mammary epithelial cells from these estrogen-treated mice (31, 32) . Semiquantitative RT-PCR demonstrated that the expression of all three genes were lower in PBP LoxP/LoxP MMTV-Cre mammary epithelial cells than that in wild type mammary epithelial cells (Fig. 3D) .
To examine the mammary lobuloalveolar proliferation stimulated by estrogen plus progesterone treatment, 3-week-old mice were ovariectomized and implanted with estrogen plus progesterone pellets. Six weeks later, the mammary glands were isolated and whole-mounted. Consistent with the finding from mice implanted with estrogen pellets, the penetrating growth of ducts into fat pad in PBP LoxP/LoxP MMTV-Cre mammary glands was much slower than that in wild type glands (Fig. 4, A-C) . The lobuloalveolar proliferation in PBP LoxP/LoxP MMTV-Cre mice was less extensive than that in wild type mice (Fig. 4, D-F) , indicating that PBP is required for the lobuloalveolar growth in response to the treatment of estrogen and progesterone.
Decreased Proliferation of PBP-deficient Mammary Epithelial Cells-To find if altered proliferation of mammary epithelial cells was involved in the defective development, 6-week-old wild type and PBP LoxP/LoxP MMTV-Cre mice were injected with bromodeoxyuridine to label the proliferating cells in mammary glands. A significant decrease in cell proliferation was consistently observed in the terminal end buds from PBP-deficient mammary glands by immunostaining with anti-BrdUrd, as compared with the wild type mammary glands (Fig. 5) , suggesting that decreased proliferation contributed to the impaired ductal elongation.
Expression of Milk Protein Genes in PBP LoxP/LoxP MMTV-Cre Mammary Glands-To investigate the differentiated functions of PBP
LoxP/LoxP MMTV-Cre mammary epithelial cells, the mRNA of milk protein genes ␤-casein, whey acidic protein, and WDNM1 from 2-day-lactating mammary glands were examined by semiquantitative RT-PCR. PBP-deficient mammary glands expressed high levels of ␤-casein, whey acidic protein (WAP) and WDNM1 mRNA similar to that by wild type mammary glands (Fig. 6) , indicating the differentiated functions of PBP-deficient mammary epithelial cells remained largely intact. colonies called mammospheres (33) . Mammospheres are clonally derived and are enriched in progenitor cells capable of differentiating along multiple lineages. We examined the ability of PBP-deficient mammary epithelial cells to form mammospheres. As expected, about 1 in 160 cells from wild type mammary glands formed mammospheres (Fig. 7A) . In contrast, only ϳ1 in 3000 cells from PBP LoxP/LoxP MMTV-Cre mammary glands generated mammospheres. Because some mammary epithelial cells from PBP LoxP/LoxP MMTV-Cre mice did not undergo PBP gene deletion and still expressed PBP protein, we examined the genotype of mammospheres generated from PBP LoxP/LoxP MMTV-Cre mammary epithelial cells. Among the 10 mammospheres examined, we found that none of the mammospheres consisted of cells with deleted PBP gene, and all mammospheres were derived from cells with intact PBP gene (Fig. 7B as the representative) , indicating that the small number of epithelial cells with intact PBP genes from PBP LoxP/LoxP MMTV-Cre mammary glands contributed to the formation of mammospheres, and PBP-deficient cells failed to form mammospheres.
PBP-deficient Epithelial Cells Were Unable to Form Mammospheres-When
Genes with Decreased Expression in PBP-deficient Mammary Glands-To gain insight to the molecular mechanism underlying the defective mammary gland development, gene profiling was performed with epithelial cells from 2 day-lactating mammary glands. Because PBP serve as a coactivator for nuclear receptors, we focused on genes that were down-regulated with PBP deficiency. We identified a total of 23 genes, expression of which in PBP-deficient mammary glands was 50% less than that from wild type mammary glands (Table I) . One of the 23 genes was homeobox A9, which is required for the expansion and differentiation of mammary epithelial cells in response to pregnancy (34) . We also observed a decrease in the expression levels of vitamin D-24-hydroxylase, which is directly regulated by vitamin D receptor (35) , two sterol regulatory element-binding protein (SREBP) target genes, stearoyl-coenzyme A desaturase 2, which is a rate-limiting enzyme in the biosynthesis of monounsaturated fatty acids, and fatty acid synthase (36) .
DISCUSSION
To understand the role of PBP in mammary gland development, we created a conditional PBP mutation in mammary glands. PBP-deficient mammary glands exhibited the retarded elongation of ducts during puberty and decreased density of alveoli during pregnancy. The lactating PBP-deficient mammary glands, which contained decreased number of lobuloalveoli with many adipocytes, failed to produce milk to nurture pups. This study demonstrated that PBP is essential for the normal mammary gland development.
PBP-deficient mammary epithelial cells showed markedly decreased proliferation, which should at least be partly responsible for the defective development of mammary glands. However, PBP-deficient mammary epithelial cells expressed abundant mRNAs of milk protein genes, indicating that the PBP-deficient mammary epithelial cells fail to form mammospheres, which are clonally derived from mammary progenitor/ stem cells (33) . PBP might be essential for the survival of mammary stem cells or the process by which mammary stem cells form mammospheres. Given the role of PBP as a nuclear receptor coactivator and the important role of estrogen receptors in mammary gland development, it is tempting to speculate that the compromised function of estrogen receptors are the cause of defective stem cells. Other potential nuclear receptor candidates are retinoic acid receptors, which are involved in many developmental processes (38, 39) . The identification of markers for mammary stem cells would help to further define the role of PBP in mammary stem cell biology.
The ductal growth during puberty is stimulated by estrogen, whereas the early side branching and alveologenesis is induced by estrogen and progesterone during pregnancy. In PBP LoxP/LoxP MMTV-Cre mice, the ductal elongation and alveolar proliferation were severely impaired. In addition, the ductal growth stimulated by direct estrogen treatment and the lobuloalveolar proliferation stimulated by estrogen plus progesterone treatment were hampered in PBP LoxP/LoxP MMTV-Cre mice. The expression of several estrogen-inducible genes as well as vitamin D receptor target gene vitamin D-24-hydroxylase was also decreased in PBP-deficient mammary glands. Consistent with the in vitro studies, which established PBP as a nuclear receptor coactivator (20, 21) , these findings provide further in vivo evidence that PBP serves as a pivotal coactivator for nuclear receptors in mammary glands.
In vitro studies found that the mediator complex could potentiate the transcriptional activity of SREBP (40) and the complex interacted with SREBP through DRIP 150, another component of the complex (41) . Gene profiling revealed that PBP deficiency decreased the expression of two SREBP target genes, stearoylcoenzyme A desaturase 2 and fatty acid synthase, implicating PBP as a coactivator for SREBP. Although PBP does not directly interact with SREBP, it might be required for exerting the transcriptional activation of mediator complex. 
